For women with newly diagnosed invasive breast cancer (BC), weight gain is associated with an increased risk for heart ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Fort Myers-based oncology testing services company Neo Genomics announced Chris Smith will retire as CEO and board member ...

Nearly half of all new cancer drugs approved by the U.S. Food and Drug Administration (FDA) over the past quarter-century ...

For patients with advanced or recurrent endometrial cancer, first-line Lenvima plus Keytruda didn’t significantly improve ...

On second thought, the FDA figures it no longer needs to discuss Exelixis’ application for Cabometyx in neuroendocrine tumors ...

TrialTranslator uses machine learning to assess cancer RCT generalizability, revealing survival gaps for high-risk patients ...

Boehringer Ingelheim announced a partnership with Synaffix to advance antibody-drug conjugates and exercised its fourth ...

Multiple TIGIT clinical data readouts anticipated throughout 2025, including >400 patients from two Phase 2 trials and one Phase 1/2 ...

IGM Biosciences Inc. said Thursday it is cutting 73% of its workforce after deciding to halt further development of a program relating to its autoimmunity-drug pipeline, sending its stock down 69% in ...

Top stocks for 2025 are from the companies that have proven growth track records and strong outlooks, with more potential ...

A two-drug combination extended OS compared with standard first-line osimertinib for certain patients with advanced lung ...